North Miami Beach, FLORIDA2 Active Studies

Heart Attack Clinical Trials in North Miami Beach, FLORIDA

Find 2 actively recruiting heart attack clinical trials in North Miami Beach, FLORIDA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
1,120
Enrolling

Recruiting Heart Attack Studies in North Miami Beach

About Heart Attack Clinical Trials in North Miami Beach

A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.

There are currently 2 heart attack clinical trials recruiting participants in North Miami Beach, FLORIDA. These studies are seeking a combined 1,120 participants. Research is being sponsored by Ionis Pharmaceuticals, Inc., Janssen Research & Development, LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Attack Clinical Trials in North Miami Beach — FAQ

Are there heart attack clinical trials in North Miami Beach?

Yes, there are 2 heart attack clinical trials currently recruiting in North Miami Beach, FLORIDA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in North Miami Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the North Miami Beach research site will contact you about next steps.

Are clinical trials in North Miami Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many North Miami Beach studies also compensate for your time and travel.

What heart attack treatments are being tested?

The 2 active trials in North Miami Beach are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.

Data updated March 2, 2026 from ClinicalTrials.gov